Delivery Order SPE2DB20D3101-SPE2DB23FQWW2
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,184.78 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a cardiovascular medication used to treat diabetes. The contract has an ultimate completion date of August 25, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,058.57 firm fixed-price delivery order covers the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of May 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,460.32 firm fixed-price delivery order contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has a completion date of June 24, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,555.23 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,876.59 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a prescription medication. The contract has an ultimate completion date of June 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,257.46 firm fixed-price delivery order is for the supply of 180 tablets of Janumet 50-1,000 mg, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of August 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,077.39 Firm Fixed Price Delivery Order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,434.68 firm fixed-price delivery order contract is for the supply of JANUMET 50-1,000 mg tablets, a prescription medication used to treat type 2 diabetes. The contract has a period of performance through November 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,173.87 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product used in the treatment of diabetes. The contract has an ultimate completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,730.96 firm fixed-price delivery order is for the supply of Janumet 50-1,000 mg tablets, a medication used to manage diabetes. The contract has a completion date of March 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FQWW2Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,973.81 firm fixed-price delivery order is for the supply of JANUMET 50-1,000 MG TABLET 180S, a pharmaceutical product used for the treatment of diabetes. The contract has an ultimate completion date of December 8, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 12/7/22 |